Puma Biotechnology
PBYI
PBYI
115 hedge funds and large institutions have $226M invested in Puma Biotechnology in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
29% less capital invested
Capital invested by funds: $319M → $226M (-$93M)
Holders
115
Holding in Top 10
–
Calls
$878K
Puts
$441K
Top Buyers
| 1 | +$7.08M | |
| 2 | +$4.91M | |
| 3 | +$2.95M | |
| 4 |
EP
Eversept Partners
New York
|
+$2.79M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$2.44M |
Top Sellers
| 1 | -$34.6M | |
| 2 | -$6.25M | |
| 3 | -$5.92M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$3.61M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.75M |